AscellaHealth’s partnership with Abeona Therapeutics in the successful commercialization of Zevaskyn™, a groundbreaking gene therapy for recessive dystrophic epidermolysis...
Calidi Biotherapeutics has secured FDA Fast Track designation for CLD-201 (Supernova), its allogeneic adipose stem-cell-loaded oncolytic virus for treating...
Cognition Therapeutics Presents Promising Zervimesine Data at AAIC 2025, Highlighting Potential in Dementia with Lewy Bodies and Alzheimer’s Disease...
Lift Biosciences Secures €12M Grant to Advance First-in-Human Trials of Novel Neutrophil Immunotherapy Lift Biosciences has been awarded a...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has delivered a negative opinion on Roche’s...
Novo Nordisk has secured a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use...
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for Pfizer...
The European Commission has granted approval for Sanofi’s Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) as...
Nordic Capital and Permira to Acquire Bavarian Nordic in $2.8B Deal Bavarian Nordic, a key player in the vaccine...
Clearmind Medicine has initiated a new clinical trial site at Tel Aviv Sourasky Medical Center (TASMC) for its Phase...
